Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2022

Oct 24, 2022

29809_dirs_2022-10-24_8e0f73c1-0f5d-44d4-a476-289b700e78cd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2022-10-21

Reporting Person: Curet Myriam (EVP & Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-10-21 Common Stock M 2000 $166.6233 Acquired 2217 Direct
2022-10-21 Common Stock S 2000 $209.7803 Disposed 217 Direct
2022-10-21 Common Stock M 6000 $174.2567 Acquired 6217 Direct
2022-10-21 Common Stock S 6000 $209.7803 Disposed 217 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-10-21 Non-Qualified Stock Option (right to buy) $166.6233 M 2000 Disposed 2029-08-15 Common Stock (2000) Direct
2022-10-21 Non-Qualified Stock Option (right to buy) $174.2567 M 6000 Disposed 2028-08-15 Common Stock (6000) Direct

Footnotes

F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 10, 2023.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $207.08 to $212.46 as follows: 1,290 shares sold at $207.08 to $208.08; 1,411 shares sold at $208.09 to $209.09; 1,600 shares sold at $209.49 to $210.41; 3,319 shares sold at $210.50 to $211.45 and 380 shares sold at $211.70 to $212.46. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.